Search
Pfizer Poised to Potentially Raise Its Bid for Metsera in Acquisition Push
1 week ago /
Read about 0 minute
Author：小编
Sources with inside knowledge of the situation have disclosed that Pfizer is in the process of formulating plans to increase its acquisition bid for Metsera, a company specializing in the development of weight-loss medications. Earlier, a judge sitting in Delaware denied Pfizer's application for a temporary injunction. This injunction was aimed at stopping Metsera from walking away from its existing merger agreement with Pfizer and from accepting a more lucrative $10 billion offer put forward by Novo Nordisk. This ruling represents the most recent development in what has turned out to be an intense and competitive bidding battle.
-
C114 Communication Network -
Communication Home
7 X 24 Track global technological trends
